HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study by Marianne Harris, Bruce Ganase, Birgit Watson, P. Richard Harrigan, Julio S. G. Montaner, Mark W. Hull

Subjects: Get full text

An Elvitegravir Nanoformulation Crosses the Blood–Brain Barrier and Suppresses HIV-1 Replication in Microglia by Yuqing Gong, Kaining Zhi, Prashanth K. B. Nagesh, Namita Sinha, Pallabita Chowdhury, Hao Chen, Santhi Gorantla, Murali M. Yallapu, Santosh Kumar

Subjects: Get full text

Inhibition of HTLV-1 Infection by HIV-1 First- and Second-Generation Integrase Strand Transfer Inhibitors by Michał S. Barski, Jordan J. Minnell, Goedele N. Maertens

Subjects: Get full text

Multiple choices for HIV therapy with integrase strand transfer inhibitors by Raffi Francois, Wainberg Mark A

Subjects: Get full text

HIV/HCV-coinfection: which role can new antiretrovirals such as integrase inhibitors play? by Vogel Martin, Nelson Mark

Subjects: Get full text

Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaquesResearch... by Charles W. Dobard, M. Melissa Peet, Kenji Nishiura, Angela Holder, Chuong Dinh, James Mitchell, George Khalil, Yi Pan, Onkar N. Singh, Timothy J. McCormick, Vivek Agrahari, Pardeep Gupta, Sriramakamal Jonnalagadda, Walid Heneine, Meredith R. Clark, J. Gerardo García-Lerma, Gustavo F. Doncel

Subjects: Get full text

A phase I study to assess safety, pharmacokinetics, and pharmacodynamics of a vaginal insert containing tenofovir alafenamide and elvitegravir by Andrea R. Thurman, Louise A. Ouattara, Nazita Yousefieh, Peter L. Anderson, Lane R. Bushman, Xi Fang, Homaira Hanif, Meredith Clark, Onkar Singh, Gustavo F. Doncel

Subjects: Get full text

New onset type 2 diabetes mellitus risks with integrase strand transfer inhibitors-based regimens: A systematic review and meta-analysis by Violet Dismas Kajogoo, Wondwossen Amogne, Girmay Medhin

Subjects: Get full text

Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages by Yuqing Gong, Pallabita Chowdhury, Narasimha M. Midde, Mohammad A. Rahman, Murali M. Yallapu, Santosh Kumar

Subjects: Get full text

A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection by Alexa Vyain Zhao, Rustin D. Crutchley, Rakesh Chowdary Guduru, Kathy Ton, Tammie Lam, Amy Cheng Min

Subjects: Get full text

Brief Histories of Retroviral Integration Research and Associated International Conferences by Duane P. Grandgenett, Alan N. Engelman

Subjects: Get full text

A phase IV, open-label three-arm study investigating the impact of a combination of tenofovir disoproxil fumarate/emtricitabine with raltegravir or dolutegravir or elvitegravir/cob... by Margherita Bracchi, Nicole Pagani, Alessia Dalla Pria, Ana Milinkovic, Nneka Nwokolo, Lervina Thomas, Sundhyia Mandalia, Marta Boffito, Graeme Moyle

Subjects: Get full text

In vitro antibacterial activity of antiretroviral drugs on key commensal bacteria from the human microbiota by Elisa Rubio-Garcia, Elisa Rubio-Garcia, Elisa Rubio-Garcia, Elisa Rubio-Garcia, Núria Ferrando, Núria Martin, Clara Ballesté-Delpierre, Clara Ballesté-Delpierre, Jose M. Miró, Jose M. Miró, Roger Paredes, Roger Paredes, Roger Paredes, Roger Paredes, Climent Casals-Pascual, Climent Casals-Pascual, Climent Casals-Pascual, Climent Casals-Pascual, Jordi Vila, Jordi Vila, Jordi Vila, Jordi Vila

Subjects: Get full text

Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patie... by Nicola Gianotti, Andrea Poli, Silvia Nozza, Laura Galli, Nadia Galizzi, Marco Ripa, Marco Merli, Alessia Carbone, Vincenzo Spagnuolo, Adriano Lazzarin, Antonella Castagna

Subjects: Get full text

Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study by José Ramón Santos, Maria Casadellà, Marc Noguera-Julian, Rafael Micán-Rivera, Pere Domingo, Antonio Antela, Joaquin Portilla, Jesús Sanz, Marta Montero-Alonso, Jordi Navarro, Mar Masiá, Mar Masiá, Nieves Valcarce-Pardeiro, Antonio Ocampo, Laura Pérez-Martínez, Coral García-Vallecillos, María Jesús Vivancos, María Jesús Vivancos, Arkaitz Imaz, José Antonio Iribarren, José Hernández-Quero, Judit Villar-García, Pilar Barrufet, Roger Paredes, Roger Paredes, INSTINCT study group, Mariona Perera, Anna Chamorro, Cristina Miranda, Nástor Sánchez, Anna Garcı́á, Núria Pérez, Juan González Garcı́á, María del Mar Gutiérrez, María Gracia Mateo, Elena Losada, Sergio Reus, Vicente Boix, Diego Torrús, Esperanza Merino, Angela Gutiérrez Liarte, Adrià Curran, Félix Gutiérrez, Anna Mariño Callejo, Alvarez Diaz Hortensia, Antonio Ocampo Hermida, Celia Miralles, Laura Labajo Leal, Guillermo Pousada, José Ramon Blanco, José Antonio Oteo, Ibarra Valvanera, Mercedes Sanz, Luis Metola, Juan Pascua, Daniel Podzamczer, Camila Piatti, Maialen Ibarguren, Laia Arbones, Marta Ruiz, Sara Cervanntes, Helena Pera, Jessica Toro, Nuria Perez-Alvarez, Anna Garcia

Subjects: Get full text

Distinct Lipidomic Profiles between People Living with HIV Treated with E/C/F/TAF or B/F/TAF: An Open-Label Prospective Cohort Study by Zhikai Wan, Junwei Su, Xueling Zhu, Xiang Liu, Yongzheng Guo, Dairong Xiang, Xiaotang Zhou, Xiaorong Peng, Ran Tao, Qing Cao, Guanjing Lang, Ying Huang, Biao Zhu

Subjects: Get full text

Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaquesResearch in context by Natalia Makarova, Tyana Singletary, M. Melissa Peet, James Mitchell, Angela Holder, Chuong Dinh, Vivek Agrahari, Maria Mendoza, Yi Pan, Walid Heneine, Meredith R. Clark, J. Gerardo García-Lerma, James M. Smith, Gustavo F. Doncel

Subjects: Get full text

Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg by Eva Natukunda, Aditya H. Gaur, Pope Kosalaraksa, Elizabeth Hellström, Renate Strehlau, Afaaf Liberty, Stephanie Cox, Rory Leisegang, Ramesh Palaparthy, Susanne Crowe, Vinicius Vieira, Kathryn Kersey, Natella Rakhmanina

Subjects: Get full text

Resistance to Integrase Inhibitors by Mathieu Métifiot, Christophe Marchand, Kasthuraiah Maddali, Yves Pommier

Subjects: Get full text

Development, Characterization and In Vivo Pharmacokinetic Assessment of Rectal Suppositories Containing Combination Antiretroviral Drugs for HIV Prevention by Kunal Jhunjhunwala, Charles W. Dobard, Sunita Sharma, Natalia Makarova, Angela Holder, Chuong Dinh, James Mitchell, Lin Wang, Junmei Zhang, Sravan Kumar Patel, Walid Heneine, Lisa C. Rohan

Subjects: Get full text